194
Views
1
CrossRef citations to date
0
Altmetric
CASE REPORTS

Lucid Dreams Associated with Pregabalin: Implications for Clinical Practice

, DO, FACOI, , ARNP, , ARNP, , PharmD & , MD
Pages 194-199 | Received 06 Aug 2021, Accepted 19 May 2022, Published online: 27 Jun 2022

References

  • Yoon SY, Oh J. Neuropathic cancer pain: prevalence, pathophysiology, and management. Korean J Intern Med. 2018;33(6):1058–69. doi:10.3904/kjim.2018.162.
  • Bruera E, Higginson I, et al. 2016. Textbook of Palliative Medicine and Supportive Care. Second Edition Pathophysiology of Chronic Pain and Neuropathic Pain. Boca Raton, FL: Taylor & Francis Group, LLC:373–481.
  • National Comprehensive Cancer Network Guidelines: (NCCN Guidelines® for Adult Cancer Pain (Version 1.2022.) © 2022 National Comprehensive Cancer Network, Inc. NCCN.org)
  • Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–45. PubMed PMID: 7249508 doi:10.1038/clpt.1981.154.
  • Thalomid (thalidomide) [prescribing information]. Summit, NJ: Celgene Corporation; February 2021.
  • Pomalyst (pomalidomide) [prescribing information]. Summit, NJ: Celgene Corporation; October 2021.
  • Terpos E, Kleber M, Engelhardt M, Zweegman S, Gay F, Kastritis E, van de Donk NWCJ, Bruno B, Sezer O, Broijl A, et al. European Myeloma Network guidelines for the management of multiple myeloma-related complications. Haematologica. 2015;100(10):1254–66. doi:10.3324/haematol.2014.117176.
  • McPherson ML, Walker KA, Davis MP, Bruera E, Reddy A, Paice J, Malotte K, Lockman DK, Wellman C, Salpeter S, et al. Safe and appropriate use of methadone in hospice and palliative care: expert consensus white paper. J Pain Symptom Manage. 2019;57(3):635–45. doi:10.1016/j.jpainsymman.2018.12.001.
  • Lyrica (pregabalin) prescribing information. New York: Pfizer Inc NY; 2020. http://labeling.pfizer.com/showlabeling.aspx?id=561. Accessed July 21, 2021.
  • Pruskowski J, Arnold R. Pregabalin in Palliative Care. Palliative Care Network of Wisconsin. https://www.mypcnow.org/fast-fact/pregabalin-in-palliative-care/.
  • FDA warns about serious breathing problems with seizure and nerve pain medicines gabapentin (Neurontin, Gralise, Horizant) and pregabalin (Lyrica, Lyrica CR) When used with CNS depressants or in patients with lung problems 12-19-2019 FDA Drug Safety Communication. https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-serious-breathing-problems-seizure-and-nerve-pain-medicines-gabapentin-neurontin. Accessed February 11, 2022.
  • Derry S, Bell RF, Straube S, Wiffen PJ, Aldington D, Moore RA. Pregabalin for neuropathic pain in adults. Cochrane Database Syst Rev. 2019;1:Cd007076.
  • Boyle J, Eriksson ME, Gribble L, Gouni R, Johnsen S, Coppini DV, Kerr D. Randomized, placebo-controlled comparison of amitriptyline, duloxetine, and pregabalin in patients with chronic diabetic peripheral neuropathic pain: impact on pain, polysomnographic sleep, daytime functioning, and quality of life. Diabetes Care. 2012;35(12):2451–8. doi:10.2337/dc12-0656.
  • Norton JW, Corbett JJ. Visual perceptual abnormalities: hallucinations and illusions. Semin Neurol. 2000;20(1):111–21. doi:10.1055/s-2000-6837.
  • Mousailidis G, Papanna B, Salmon A, Sein A, Al-Hillawi Q. Pregabalin induced visual hallucinations - a rare adverse reaction. BMC Pharmacol Toxicol. 2020;21(1):16. doi:10.1186/s40360-020-0395-6.
  • Antrobus J, Wamsley E. Sleep mentation in REM and NREM: A cognitive neuroscience perspective. 2017. doi:10.1016/B978-0-12-809324-5.02859-5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.